Sepsis Care Revolutionized
We are improving sepsis identification and resuscitation with a novel medical device
Sepsis Care Revolutionized
We are improving sepsis identification and resuscitation with a novel medical device
Why Choose ProMedix
Problem
Innovation
Innovation
While research has shown that capillary refill time (CRT) is a sound, and advantageous, way to guide sepsis resuscitation, the current subjective method of estimating CRT is unreliable and leads to poor diagnoses.
Innovation
Innovation
Innovation
FlowSense, ProMedix's digital capillary refill time sensor, makes an objective, repeatable measurement that supports accurate diagnosis.
Clinical
Clinical
Clinical
The 2021 Surviving Sepsis Guidelines recommends using capillary refill time to guide resuscitation as an adjunct to other measures of perfusion.
Solution
Clinical
Clinical
Our sensor improves the speed and accuracy of sepsis diagnosis by providing a reliable and accurate CRT, which is a marker of distal perfusion.
The FlowSense CRT Sensor
A non-invasive avenue to assess capillary refill time (CRT), and therefore, distal perfusion.
The device connects via Bluetooth to a mobile application that guides the user through pressure application and release. Results are conveyed via the mobile application to a secure server. It requires little training and is simple enough that it can even be used in home-health settings.
Our Team
ProMedix is led by renowned clinical professionals who saw the need for improvement in the critical care space and decided to make a change.
Partnerships
ProMedix is backed by industrial and institutional leaders who see the value in novel medical technologies. We are supported by multiple organizations who provide valuable mentorship, capital, and connections with world class professionals.